What Does Octapharma AG Do?

Total employees11000
HeadquartersLachen
Founded1983

Octapharma AG is one of the largest human protein product manufacturers in the world, developing and producing high-quality human proteins from human plasma and human cell lines. Headquartered in Lachen, Switzerland, Octapharma was founded in 1983 by Wolfgang Marguerre. The company is dedicated to patient care and medical innovation, focusing on three therapeutic areas: Haematology, Immunotherapy, and Critical Care. Octapharma employs thousands worldwide and distributes its life-saving products to patients in 118 countries. They own state-of-the-art production facilities and a network of plasma donation centers (Octapharma Plasma Inc. in the US and Germany).

Where Is Octapharma AG's Headquarters?

HQ Function

The Lachen headquarters serves as the central hub for Octapharma's global operations, strategic planning, corporate governance, research and development oversight, and international commercial activities.

Notable Features:

The headquarters is a modern facility, likely designed to foster collaboration and reflect Swiss precision and quality. While specific architectural awards aren't widely publicized, its location and design are intended to support a high-performance, innovative environment.

Work Culture:

The work culture at Octapharma HQ is characterized by a strong emphasis on scientific excellence, quality, patient focus, and entrepreneurial spirit. It fosters an international, collaborative environment driven by its mission to provide life-saving therapies.

HQ Significance:

Its Swiss location provides political and economic stability, access to a highly skilled workforce, and a strong reputation in the pharmaceutical industry. The headquarters is pivotal for coordinating global R&D, manufacturing, and distribution efforts.

Values Reflected in HQ: The headquarters' operations and environment aim to reflect Octapharma's core values: Ownership, Integrity, Leadership, Sustainability, and Entrepreneurship.

Location:

Octapharma AG operates globally, with its products available in 118 countries. This extensive reach is supported by a network of five state-of-the-art production facilities in Austria, France, Germany, Mexico, and Sweden, numerous R&D sites, over 190 plasma donation centers (primarily in the US and Germany through Octapharma Plasma, Inc.), and commercial offices worldwide. Key global functions include research and development, manufacturing, quality assurance, regulatory affairs, supply chain management, and sales & marketing, all coordinated to ensure patient access to their human protein therapies.

Street Address:

Seidenstrasse 2

City:

Lachen

State/Province:

SZ (Schwyz)

Country:

Switzerland

Where Else Does Octapharma AG Operate Around the World?

Vienna, Austria

Address: Oberlaaer Strasse 235, 1100 Wien, Austria

Serves as a critical hub for European manufacturing and research, supplying products globally and supporting innovation across therapeutic areas.

Stockholm, Sweden

Address: Lars Forssells gata 23, 112 15 Stockholm, Sweden

Key Nordic research and production center, contributing to Octapharma's innovative product pipeline, especially in recombinant therapies.

Springe, Germany

Address: Elisabeth-Selbert-Strasse 11, 31832 Springe, Germany

Strengthens Octapharma's manufacturing capacity in Europe, ensuring supply of critical plasma-derived medicines.

Lingolsheim, France

Address: 72 Rue du Maréchal Foch, 67380 Lingolsheim, France

Contributes to Octapharma's European production network and serves the French and international markets.

Hoboken, New Jersey, USA

Address: 117 Park Avenue, Hoboken, NJ 07030, USA

Manages and expands Octapharma's presence in the critical U.S. market for its hematology, immunotherapy, and critical care products.

Charlotte, North Carolina, USA

Address: 1210 Northpointe Centre Drive, Charlotte, NC 28216, USA

Crucial for securing a high-quality plasma supply, the raw material for Octapharma's life-saving therapies.

Buying Intent Signals for Octapharma AG

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Octapharma AG? Meet the Executive Team

As of April 2025, Octapharma AG' leadership includes:

Wolfgang Marguerre - Chairman and Chief Executive Officer
Roger Mächler - Chief Operating Officer and Member of the Board
Dr. Barbara Rangger - Chief Financial Officer and Member of the Board
Olaf Walter - Head of International Business Units, Human Resources & Corporate Communications, Member of the Board
Tobias Marguerre - Member of the Board
Flemming Nielsen - President of Octapharma Plasma USA, and Member of the Board of Octapharma AG

Who's Investing in Octapharma AG?

Octapharma AG has been backed by several prominent investors over the years, including:

Octapharma AG is a privately owned and independent company. It is majority-owned by the Marguerre family, with Wolfgang Marguerre as the founder.

What Leadership Changes Has Octapharma AG Seen Recently?

Hire0
Exits0

As a privately-held company, Octapharma AG does not publicize all executive movements as frequently as publicly traded companies. Major board-level changes are typically announced via official press releases. No major, widely publicized changes to the core executive board (as listed) have been noted in the last 12-18 months, indicating stability in top leadership. Any changes would likely be internal promotions or strategic appointments announced on their corporate website.

What Technology (Tech Stack) Is Used byOctapharma AG?

Discover the tools Octapharma AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Octapharma AG Email Formats and Examples

Octapharma AG commonly uses the [first].[last]@octapharma.com email format for its employees. Variations might exist, but this is a widely observed pattern.

[first].[last]@octapharma.com

Format

john.doe@octapharma.com

Example

85%

Success rate

What's the Latest News About Octapharma AG?

Octapharma AG WebsiteMay 7, 2024

Octapharma AG news title: New data on Octapharma’s subcutaneous immunoglobulin cutaquig® confirm good efficacy, safety and tolerability in children with primary immunodeficiency

Octapharma announced new data from the PEDIQUIG study, confirming the good efficacy, safety and tolerability of its 16.5% subcutaneous immunoglobulin (SCIG), cutaquig®, in children with primary immunodeficiency (PID). The findings were presented at the Clinical Immunology Society (CIS) 2024 Annual Meeting....more

Octapharma AG WebsiteApril 16, 2024

Octapharma AG news title: Octapharma reports strong growth in 2023 and significant investments to meet increasing patient needs

Octapharma Group announced strong financial performance for 2023, with sales of €3.268 billion, a 14.1% increase over 2022. The company also reported significant investments in R&D, plasma collection capacity, and production capabilities to meet the growing global demand for its plasma-derived therapies....more

Octapharma AG WebsiteFebruary 29, 2024

Octapharma AG news title: Octapharma to present new data from across its haematology portfolio at EHC 2024

Octapharma announced it would present new data from its haematology portfolio at the European Association for Haemophilia and Allied Disorders (EAHAD) Congress 2024, highlighting its ongoing commitment to advancing care for patients with bleeding disorders....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Octapharma AG, are just a search away.